Market revenue in 2021 | USD 228.7 million |
Market revenue in 2030 | USD 509.0 million |
Growth rate | 9.3% (CAGR from 2021 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Preclinical |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preclinical, Clinical |
Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 66.11% in 2021. Horizon Databook has segmented the Asia Pacific large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
This can be attributed to growing healthcare expenditure in the emerging economies of the region, especially India and China. Favorable government initiatives in are anticipated to improve healthcare R&D, which will also drive the market for large molecule bioanalytical testing.
Demographic changes in the region, especially in countries such as China, India, and Japan, will also propel market demand. Furthermore, advancements in pharmaceuticals and biopharmaceuticals in the region coupled with rising number of clinical trials will augment the regional market growth over the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific large molecule bioanalytical testing services market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account